Celgene Avilomics Research, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Celgene Avilomics Research, Inc..The latest application filed is for "protein kinase conjugates and inhibitors".
Company Profile
4.72.87
- Celgene Avilomics Research, Inc. - Bedford MA US
- Celgene Avilomics Research, Inc. - Cambridge MA US
- Celgene Avilomics Research, Inc - Bedford MA
- Celgene Avilomics Research, Inc.; - US
Patent Activity
| Patent | Date |
|---|---|
| Protein kinase conjugates and inhibitors Grant 10,662,195 - Singh , et al. | 2020-05-26 |
| Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20170173011 - Westlin, III; William Frederick ; et al. | 2017-06-22 |
| Protein Kinase Conjugates and Inhibitors App 20170174691 - Singh; Juswinder ; et al. | 2017-06-22 |
| Hcv Protease Inhibitors And Uses Thereof App 20170137463 - Niu; Deqiang ; et al. | 2017-05-18 |
| Erk Inhibitors And Uses Thereof App 20170137406 - Haq; Nadia ; et al. | 2017-05-18 |
| Mk2 Inhibitors And Uses Thereof App 20170114073 - Alexander; Matthew David ; et al. | 2017-04-27 |
| Heteroaryl Compounds And Uses Thereof App 20170100397 - Singh; Juswinder ; et al. | 2017-04-13 |
| Heteroaryl Compounds And Uses Thereof App 20170095475 - Tester; Richland Wayne ; et al. | 2017-04-06 |
| Besylate salt of a BTK inhibitor Grant 9,604,936 - Witowski , et al. March 28, 2 | 2017-03-28 |
| ERK inhibitors and uses thereof Grant 9,561,228 - Haq , et al. February 7, 2 | 2017-02-07 |
| Heterocyclic Compounds and Uses Thereof App 20170027937 - Lee; Kwangho ; et al. | 2017-02-02 |
| Protein kinase conjugates and inhibitors Grant 9,556,426 - Singh , et al. January 31, 2 | 2017-01-31 |
| Heteroaryl compounds and uses thereof Grant 9,549,927 - Tester , et al. January 24, 2 | 2017-01-24 |
| Solid forms of an epidermal growth factor receptor kinase inhibitor Grant 9,539,255 - Lai January 10, 2 | 2017-01-10 |
| Salts of an epidermal growth factor receptor kinase inhibitor Grant 9,540,335 - Lai , et al. January 10, 2 | 2017-01-10 |
| ERK inhibitors and uses thereof Grant 9,504,686 - Haq , et al. November 29, 2 | 2016-11-29 |
| Mutant-selective Egfr Inhibitors And Uses Thereof App 20160332994 - Lee; Kwangho ; et al. | 2016-11-17 |
| Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase Grant 9,492,471 - Daniel , et al. November 15, 2 | 2016-11-15 |
| Hcv Protease Inhibitors And Uses Thereof App 20160326216 - Niu; Deqiang ; et al. | 2016-11-10 |
| Heteroaryl Compounds And Uses Thereof App 20160311780 - Singh; Juswinder ; et al. | 2016-10-27 |
| Heteroaryl Compounds And Uses Thereof App 20160303121 - Singh; Juswinder ; et al. | 2016-10-20 |
| Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20160287588 - Witowski; Steven Richard ; et al. | 2016-10-06 |
| MK2 inhibitors and uses thereof Grant 9,458,175 - Alexander , et al. October 4, 2 | 2016-10-04 |
| Heteroaryl Compounds And Uses Thereof App 20160279127 - Singh; Juswinder ; et al. | 2016-09-29 |
| Hcv Protease Inhibitors And Uses Thereof App 20160243249 - Petter; Russell C. ; et al. | 2016-08-25 |
| HCV protease inhibitors and uses thereof Grant 9,422,333 - Niu , et al. August 23, 2 | 2016-08-23 |
| Hcv Protease Inhibitors And Uses Thereof App 20160235805 - Petter; Russell C. ; et al. | 2016-08-18 |
| Heteroaryl compounds and uses thereof Grant 9,415,049 - Tester , et al. August 16, 2 | 2016-08-16 |
| Mutant-selective EGFR inhibitors and uses thereof Grant 9,409,887 - Lee , et al. August 9, 2 | 2016-08-09 |
| 2,4-disubstituted pyrimidines as kinase inhibitors Grant 9,409,921 - Singh , et al. August 9, 2 | 2016-08-09 |
| Heteroaryl Compounds And Uses Thereof App 20160221966 - D'Agostino; Laura Akullian ; et al. | 2016-08-04 |
| 2,4-disubstituted pyrimidine compounds useful as kinase inhibtors Grant 9,375,431 - Lee , et al. June 28, 2 | 2016-06-28 |
| Methods of treating a Bruton's Tyrosine Kinase disease or disorder Grant 9,364,476 - Witowski , et al. June 14, 2 | 2016-06-14 |
| Heteroaryl Compounds And Uses Thereof App 20160159774 - Schwartz; C. Eric ; et al. | 2016-06-09 |
| Heteroaryl Compounds And Uses Thereof App 20160130236 - Lee; Kwangho ; et al. | 2016-05-12 |
| Heteroaryl compounds and uses thereof Grant 9,321,786 - D'Agostino , et al. April 26, 2 | 2016-04-26 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,296,737 - Singh , et al. March 29, 2 | 2016-03-29 |
| Substituted pyrimidines as protein kinase inhibitors Grant 9,296,704 - Singh , et al. March 29, 2 | 2016-03-29 |
| Erk Inhibitors And Uses Thereof App 20160082008 - Haq; Nadia ; et al. | 2016-03-24 |
| Mk2 Inhibitors And Uses Thereof App 20160075720 - Alexander; Matthew David ; et al. | 2016-03-17 |
| Heteroaryl Compounds And Uses Thereof App 20160046634 - D'Agostino; Laura Akullian ; et al. | 2016-02-18 |
| Heteroaryl Compounds And Uses Thereof App 20160030426 - Tester; Richland Wayne ; et al. | 2016-02-04 |
| Solid Forms Of An Epidermal Growth Factor Receptor Kinase Inhibitor App 20160022677 - Lai; Mei | 2016-01-28 |
| Heteroaryl compounds and uses thereof Grant 9,238,629 - Lee , et al. January 19, 2 | 2016-01-19 |
| Erk Inhibitors And Uses Thereof App 20160002176 - Haq; Nadia ; et al. | 2016-01-07 |
| Heteroaryl Compounds And Uses Thereof App 20150374690 - Tester; Richland ; et al. | 2015-12-31 |
| Mk2 Inhibitors And Uses Thereof App 20150376208 - ALEXANDER; Matthew David ; et al. | 2015-12-31 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,212,181 - Singh , et al. December 15, 2 | 2015-12-15 |
| Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor App 20150344441 - Lai; Mei ; et al. | 2015-12-03 |
| Heteroaryl Compounds And Uses Thereof App 20150328223 - Singh; Juswinder ; et al. | 2015-11-19 |
| HCV protease inhibitors and uses thereof Grant 9,163,061 - Petter , et al. October 20, 2 | 2015-10-20 |
| ERK inhibitors and uses thereof Grant 9,145,387 - Haq , et al. September 29, 2 | 2015-09-29 |
| Heterocyclic Compounds And Uses Thereof App 20150252019 - Singh; Juswinder ; et al. | 2015-09-10 |
| Heteroaryl compounds and uses thereof Grant 9,126,950 - Tester , et al. September 8, 2 | 2015-09-08 |
| Heterocyclic Compounds And Uses Thereof App 20150246040 - Lee; Kwangho ; et al. | 2015-09-03 |
| Salts of an epidermal growth factor receptor kinase inhibitor Grant 9,108,927 - Lai , et al. August 18, 2 | 2015-08-18 |
| Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20150216865 - Westlin, III; William Frederick ; et al. | 2015-08-06 |
| Heterocyclic compounds and uses thereof Grant 9,067,929 - Singh , et al. June 30, 2 | 2015-06-30 |
| Hcv Protease Inhibitors And Uses Thereof App 20150175657 - Niu; Deqiang ; et al. | 2015-06-25 |
| Heteroaryl Compounds And Uses Thereof App 20150174128 - Tester; Richland ; et al. | 2015-06-25 |
| Solid forms of an epidermal growth factor receptor kinase inhibitor Grant 9,056,839 - Lai June 16, 2 | 2015-06-16 |
| 4,6-disubstituted pyrimidines useful as kinase inhibitors Grant 9,040,541 - Singh , et al. May 26, 2 | 2015-05-26 |
| Methods Of Treating A Disease Or Disorder Associated With Bruton's Tyrosine Kinase App 20150139979 - Daniel; Tom ; et al. | 2015-05-21 |
| HCV protease inhibitors and uses thereof Grant 8,980,935 - Niu , et al. March 17, 2 | 2015-03-17 |
| Heterocyclic compounds and uses thereof Grant 8,975,249 - Lee , et al. March 10, 2 | 2015-03-10 |
| Methods Of Treating A Disease Or Disorder Associated With Bruton's Tyrosine Kinase App 20150064173 - Daniel; Tom ; et al. | 2015-03-05 |
| Methods Of Treating A Disease Or Disorder Associated With Bruton's Tyrosine Kinase App 20150064172 - Daniel; Tom ; et al. | 2015-03-05 |
| Hcv Protease Inhibitors And Uses Thereof App 20150031106 - Niu; Deqiang ; et al. | 2015-01-29 |
| Mutant-selective Egfr Inhibitors And Uses Thereof App 20150025055 - Lee; Kwangho ; et al. | 2015-01-22 |
| Hcv Protease Inhibitors And Uses Thereof App 20140323465 - Niu; Deqiang ; et al. | 2014-10-30 |
| Heteroaryl Compounds And Uses Thereof App 20140303165 - Singh; Juswinder ; et al. | 2014-10-09 |
| Heteroaryl Compounds And Uses Thereof App 20140296233 - D'Agostino; Laura Akullian ; et al. | 2014-10-02 |
| Erk Inhibitors And Uses Thereof App 20140228322 - Haq; Nadia ; et al. | 2014-08-14 |
| Mutant-selective EGFR inhibitors and uses thereof Grant 8,796,255 - Lee , et al. August 5, 2 | 2014-08-05 |
| Heteroaryl Compounds And Uses Thereof App 20140213574 - Singh; Juswinder ; et al. | 2014-07-31 |
| HCV protease inhibitors and uses thereof Grant 8,778,877 - Niu , et al. July 15, 2 | 2014-07-15 |
| Heteroaryl Compounds And Uses Thereof App 20140179720 - Tester; Richland ; et al. | 2014-06-26 |
| 4,6-diaminopyrimidines useful as kinase inhibitors Grant 8,748,606 - Singh , et al. June 10, 2 | 2014-06-10 |
| HCV protease inhibitors and uses thereof Grant 8,741,837 - Niu , et al. June 3, 2 | 2014-06-03 |
| Methods Of Treating A Disease Or Disorder Associated With Bruton's Tyrosine Kinase App 20140142129 - Daniel; Tom ; et al. | 2014-05-22 |
| Methods Of Treating A Disease Or Disorder Associated With Bruton's Tyrosine Kinase App 20140140991 - Daniel; Tom ; et al. | 2014-05-22 |
| Methods Of Treating A Disease Or Disorder Associated With Bruton's Tyrosine Kinase App 20140142128 - Daniel; Tom ; et al. | 2014-05-22 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,710,222 - Singh , et al. April 29, 2 | 2014-04-29 |
| Heterocyclic Compounds And Uses Thereof App 20140073661 - Singh; Juswinder ; et al. | 2014-03-13 |
| Besylate Salt Of A Btk Inhibitor App 20140057929 - Witowski; Steven Richard ; et al. | 2014-02-27 |
| Hcv Protease Inhibitors And Uses Thereof App 20130338062 - Niu; Deqiang ; et al. | 2013-12-19 |
| 2,4-diaminopyrimidines useful as kinase inhibitors Grant 8,609,679 - Singh , et al. December 17, 2 | 2013-12-17 |
| Methods for identifying HCV protease inhibitors Grant 8,603,737 - Hagel , et al. December 10, 2 | 2013-12-10 |
| Heterocyclic compounds and uses thereof Grant 8,586,600 - Singh , et al. November 19, 2 | 2013-11-19 |
| Besylate salt of a BTK inhibitor Grant 8,563,568 - Witowski , et al. October 22, 2 | 2013-10-22 |
| Solid Forms Of An Epidermal Growth Factor Receptor Kinase Inhibitor App 20130267530 - Lai; Mei | 2013-10-10 |
| Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor App 20130267531 - Lai; Mei ; et al. | 2013-10-10 |
| HCV protease inhibitors and uses thereof Grant 8,524,760 - Niu , et al. September 3, 2 | 2013-09-03 |
| Heteroaryl Compounds And Uses Thereof App 20130217688 - Singh; Juswinder ; et al. | 2013-08-22 |
| Heteroaryl Compounds And Uses Thereof App 20130165462 - Singh; Juswinder ; et al. | 2013-06-27 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,450,335 - Singh , et al. May 28, 2 | 2013-05-28 |
| Hcv Protease Inhibitors And Uses Thereof App 20130131105 - Petter; Russell C. ; et al. | 2013-05-23 |
| 4,6-disubstituted pyrimidines useful as kinase inhibitors Grant 8,445,498 - Singh , et al. May 21, 2 | 2013-05-21 |
| Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20130109709 - Witowski; Steven Richard ; et al. | 2013-05-02 |
| Heteroaryl Compounds And Uses Thereof App 20130072469 - Singh; Juswinder ; et al. | 2013-03-21 |
| Heteroaryl Compounds And Uses Thereof App 20130065879 - Singh; Juswinder ; et al. | 2013-03-14 |
| Heteroaryl Compounds And Uses Thereof App 20130065899 - Singh; Juswinder ; et al. | 2013-03-14 |
| Heteroaryl Compounds And Uses Thereof App 20130065892 - Singh; Juswinder ; et al. | 2013-03-14 |
| Hcv Protease Inhibitors And Uses Thereof App 20130017991 - Niu; Deqiang ; et al. | 2013-01-17 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,338,439 - Singh , et al. December 25, 2 | 2012-12-25 |
| 4,6-disubstitued pyrimidines useful as kinase inhibitors Grant 8,329,901 - Singh , et al. December 11, 2 | 2012-12-11 |
| HCV protease inhibitors and uses thereof Grant 8,309,685 - Petter , et al. November 13, 2 | 2012-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 